-
From Development to Reimbursement Evidence-Generation Strategies for HealthTech in Europe
Sep 9, 2025, 16:22 PM -
A Scoping Review of Resource Modeling in HTA Using Discrete Event Simulation
Sep 9, 2025, 16:22 PM -
Potential Benefits of Universal Influenza Vaccination on Health Outcomes and Costs in Mexico
Sep 9, 2025, 16:22 PM -
Clinical Outcomes In HTA Appraisal Reports Of Oncology Medicines In Portugal: A Cross-Sectional Analysis
Sep 9, 2025, 16:22 PM -
A Review of Approaches to Select Instruments and Items to Measure Patient Reported Tolerability in Clinical Trials in Oncology
Sep 9, 2025, 16:22 PM -
Using Natural Language Processing to Identify Sequencing Patterns in Advanced Urothelial Carcinoma: A Real-World Observational Study
Sep 9, 2025, 16:22 PM -
Increases in Frailty Following Hospitalization With COVID-19: An Analysis of Claims and Annual Health Check Data
Sep 9, 2025, 16:22 PM -
A Cross-Sectional Analysis of the Reimbursement Obligation for CAR-T Drugs by Huiminbao Insurances in Mainland China of 2024
Sep 9, 2025, 16:22 PM -
Accessibility and Time to Reimbursement of Treatments With Substantial Benefit: A Comparative Analysis Focused on Inequalities Between Different European Countries and Different Tumor Types
Sep 9, 2025, 16:22 PM -
Impact of Glucagon-Like Peptide-1 Treatments on Patient-Reported Outcomes in Type 2 Diabetes Mellitus
Sep 9, 2025, 16:22 PM -
Do Health Technology Assessments (HTA) Consider Racial Health Inequalities? A Case Study of NICE HTAs for Chronic Kidney Disease Hypertension and Diabetes
Sep 9, 2025, 16:22 PM -
Mental and Behavioral Health Disorders MBHD Among Patients With Metastatic and Nonmetastatic Cancer: A Claims-Based Analysis
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Composite Materials for Hard Dental Tissue Defect Restorations From Budget Financing in Wartime in Ukraine
Sep 9, 2025, 16:22 PM -
The Association Between Generalized Anxiety Disorder Symptom Severity and Comorbid Health Conditions Among the US General Adult Population
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Mixed-Approach Maternal RSVpreF/Infant Nirsevimab Immunization vs. Nirsevimab Alone for Prevention of Respiratory Syncytial Virus in Spain
Sep 9, 2025, 16:22 PM -
Adjuvanted RSVpreF3 Vaccine for Respiratory Syncytial Virus Prevention in the United Kingdom, Spain, and Australia: A Climate Change Impact Analysis
Sep 9, 2025, 16:22 PM -
Health Utilities Among Patients With Chronic Rhinosinusitis With Nasal Polyps: An Exploratory Analysis From the WAYPOINT Trial
Sep 9, 2025, 16:22 PM -
Advancing Patient Involvement in Health Technology Assessment
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life Measured by EQ-5D Utility Among Patients With TGCT: A Trial-Based Analysis of EQ-5D Data From Patients in the MOTION Trial
Sep 9, 2025, 16:22 PM -
The Real-World Impact of Step Therapy and Prior Authorization on Patients, Clinicians, and US Health Plans: Lessons to Be Learned in Europe
Sep 9, 2025, 16:22 PM
